It is already known that p21 expression can increase after inhibition of the HDACs in different cancer models [35,55,56,57], and that the inhibition of DNMT1 and HDACs results in increased p21 expression in lung cancer models [58]. The gene discussed is DNMT1; the disease is lung carcinoma.